Differences in the frequency of 23S rRNA gene mutations in mycoplasma pneumoniae between children and adults with community-acquired pneumonia: Clinical impact of mutations conferring macrolide resistance

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 12, 2012, Pages 6393-6396

  Yoo, Soo Jin ^a   Kim, Hyo Bin ^a   Choi, Sang Ho ^b   Lee, Sang Oh ^b   Kim, Sung Han ^b   Hong, Sang Bum ^b   Sung, Heungsup ^b   Kim, Mi Na ^b  

^a Inje University College of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL RNA; BETA LACTAM ANTIBIOTIC; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RNA 23S;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; CHILD; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FEVER; GENE MUTATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MUTATION RATE; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; RNA SEQUENCE; SCHOOL CHILD; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; DNA; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; INFANT; MACROLIDES; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MUTATION; MYCOPLASMA PNEUMONIAE; NASOPHARYNX; PNEUMONIA, MYCOPLASMA; POLYMERASE CHAIN REACTION; RNA, RIBOSOMAL, 23S; YOUNG ADULT;

EID: 84869236203     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01421-12     Document Type: Article

References (22)

1. Bebear CM, Pereyre S. 2005. Mechanisms of drug resistance in Mycoplasma pneumoniae. Curr. Drug Targets Infect. Disord. 5:263-271.
2. Cao B, et al. 2010. High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China. Clin. Infect. Dis. 51:189-194.
3. Isozumi R, Yoshimine H, Morozumi M, Ubukata K, Ariyoshi K. 2009. Adult community-acquired pneumonia caused by macrolide resistant Mycoplasma pneumoniae. Respirology 14:1206-1208.
4. Jacobs MR, Johnson CE. 2003. Macrolide resistance: an increasing concern for treatment failure in children. Pediatr. Infect. Dis. J. 22:S131-S138.
5. Klappenbach JA, Dunbar JM, Schmidt TM. 2000. rRNA operon copy number reflects ecological strategies of bacteria. Appl. Environ. Microbiol. 66:1328-1333.
6. Koh E, Kim S. 2010. Decline in erythromycin resistance in group A streptococci from acute pharyngitis due to changes in the emm genotypes rather than restriction of antibiotic use. Korean J. Lab Med. 30:485-490.
7. Liu Y, et al. 2009. Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from Shanghai, China. Antimicrob. Agents Chemother. 53:2160-2162.
8. Matsubara K, et al. 2009. A comparative clinical study of macrolide-sensitive and macrolide-resistant Mycoplasma pneumoniae infections in pediatric patients. J. Infect. Chemother. 15:380-383.
9. Miyashita N, et al. 2012. Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia. BMC Infect. Dis. 12:126. doi:10.1186/1471-2334-12-126.
10. Miyashita N, et al. 2011. Community-acquired macrolide-resistant Mycoplasma pneumoniae pneumonia in patients more than 18 years of age. J. Infect. Chemother. 17:114-118.
11. Morozumi M, et al. 2008. Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia. Antimicrob. Agents Chemother. 52:348-350.
12. Morozumi M, Takahashi T, Ubukata K. 2010. Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia. J. Infect. Chemother. 16:78-86.
13. Narita M. 2011. Two unexpected phenomena in macrolide-resistant Mycoplasma pneumoniae infection in Japan and the unique biological characteristics of Mycoplasma pneumoniae. J. Infect. Chemother. 17:735-736.
14. Oh CE, Choi EH, Lee HJ. 2010. Detection of genetic mutations associated with macrolide resistance of Mycoplasma pneumoniae. Korean J. Pediatr. 53:178-183.
15. Peuchant O, et al. 2009. Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis. J. Antimicrob. Chemother. 64:52-58.
16. Suzuki S, et al. 2006. Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae. Antimicrob. Agents Chemother. 50:709-712.
17. Waites KB, Balish MF, Atkinson TP. 2008. New insights into the pathogenesis and detection of Mycoplasma pneumoniae infections. Future Microbiol. 3:635-648.
18. Waites KB, Taylor-Robinson D. 2011. Mycoplasma and Ureaplasma, p 970-985. In Versalovic J, et al (ed), Manual of clinical microbiology, 10th ed, vol 1. ASM Press, Washington, DC.
19. Wolff BJ, Thacker WL, Schwartz SB, Winchell JM. 2008. Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis. Antimicrob. Agents Chemother. 52:3542-3549.
20. Xin D, et al. 2009. Molecular mechanisms of macrolide resistance in clinical isolates of Mycoplasma pneumoniae from China. Antimicrob. Agents Chemother. 53:2158-2159.
21. Youn YS, Lee KY. 2012. Mycoplasma pneumoniae pneumonia in children. Korean J. Pediatr. 55:42-47.
22. Zhao F, et al. 2012. Antibiotic sensitivity of 40 Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant isolates from Beijing, China. Antimicrob. Agents Chemother. 56:1108-1109.